Rahaf Omaish

Role not yet determined Is this you? Add your title

UAMS

Also affiliated: University of Arkansas Medical Center (2025)

1 h-index 8 pubs 2 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Rahaf Omaish's research focuses on understanding adverse events and treatment outcomes in patients undergoing complex medical interventions. Her work includes investigating acute kidney injury (AKI) in recipients of chimeric antigen receptor T-cell (CAR-T) therapy, with publications examining clinical characteristics, risk factors, and their impact on mortality. Omaish also studies hypophosphatemia as a potential marker for immune effector cell-associated neurotoxicity syndrome (ICANS) in these patients. Her research extends to other critical care areas, including exploring the potential of triple therapy in diabetic kidney disease and analyzing the role of B-cell maturation antigen (BCMA) immunohistochemistry in multiple myeloma patients. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Lean Alkhatib and Abedalrahman Almashayekh, on several shared publications.

Metrics

h-index: 1
Publications: 8
Citations: 2

Selected Publications

Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality (2026)

Transplantation and Cellular Therapy DOI OpenAlex
Potential of Triple Therapy in Diabetic Kidney Disease (2025)

Journal of the American Society of Nephrology 1 citation DOI OpenAlex
AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)

Journal of the American Society of Nephrology DOI OpenAlex
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients (2025)

Journal of the American Society of Nephrology DOI OpenAlex
Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy (2025)

Journal of the American Society of Nephrology 1 citation DOI OpenAlex
Iptacopan treatment for recurrent dense deposit disease after kidney transplant: A case report (2025)

SAGE Open Medical Case Reports DOI OpenAlex
MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma. (2025)

Journal of Clinical Oncology DOI OpenAlex
B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies. (2025)

Journal of Clinical Oncology DOI OpenAlex